Gene Therapy Biopharma uniQure Sets Terms For $64 Million IPO

Published: Jan 27, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

uniQure, which develops gene therapies for the treatment of orphan diseases, announced terms for its IPO on Friday. The Amsterdam, Netherlands-based company plans to raise $64 million by offering 4.6 million shares at a price range of $13 to $15. At the midpoint of the proposed range, uniQure would command a market value of $235 million.

Help employers find you! Check out all the jobs and post your resume.

Back to news